Share
Therapeutic Treatment for Benign Prostatic Hyperplasia
Kirby, Roger S. ; Mcconnell, John D. ; Fitzpatrick, John (Author)
·
CRC Press
· Hardcover
Therapeutic Treatment for Benign Prostatic Hyperplasia - Kirby, Roger S. ; McConnell, John D. ; Fitzpatrick, John
£ 153.00
£ 170.00
You save: £ 17.00
Choose the list to add your product or create one New List
✓ Product added successfully to the Wishlist.
Go to My WishlistsIt will be shipped from our warehouse between
Tuesday, August 06 and
Thursday, August 08.
You will receive it anywhere in United Kingdom between 1 and 3 business days after shipment.
Synopsis "Therapeutic Treatment for Benign Prostatic Hyperplasia"
The spectrum of available treatment options for benign prostatic hyperplasia (BPH) is matched by the spectrum of disease severity, and with up to 90% of men in their 80s suffering from BPH to some extent, it is imperative that patients are offered the full range of options to manage the disease. Pharmacologic therapies available for the treatment of lower urinary tract symptoms secondary to BPH include alpha-adrenoceptor antagonists, such as terazosin, doxazosin, alfuzosin and tamsulosin, and the 5-alpha-reductase inhibitors, finasteride and dutasteride. Other strategies, such as plant-derived medication or watchful waiting, are applied to varying extents. Derived from the benchmark title on BPH - Textbook of Benign Prostatic Hyperplasia - this well written and highly illustrated guide covers all these therapies and presents physicians with all they need to know to successfully manage the disease.
